These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 38814742)
1. Mast cell conditions and drug allergy: when to suspect and how to manage. Olivieri B; Ghilarducci A; Nalin F; Bonadonna P Curr Opin Allergy Clin Immunol; 2024 Aug; 24(4):195-202. PubMed ID: 38814742 [TBL] [Abstract][Full Text] [Related]
2. Mas-Related G Protein-Coupled Receptor-X2 (MRGPRX2) in Drug Hypersensitivity Reactions. Porebski G; Kwiecien K; Pawica M; Kwitniewski M Front Immunol; 2018; 9():3027. PubMed ID: 30619367 [TBL] [Abstract][Full Text] [Related]
3. Novel Insights on MRGPRX2-Mediated Hypersensitivity to Neuromuscular Blocking Agents And Fluoroquinolones. Elst J; Maurer M; Sabato V; Faber MA; Bridts CH; Mertens C; Van Houdt M; Van Gasse AL; van der Poorten MM; De Puysseleyr LP; Hagendorens MM; Van Tendeloo VF; Lion E; Campillo-Davo D; Ebo DG Front Immunol; 2021; 12():668962. PubMed ID: 34385999 [TBL] [Abstract][Full Text] [Related]
4. Reclassifying Anaphylaxis to Neuromuscular Blocking Agents Based on the Presumed Patho-Mechanism: IgE-Mediated, Pharmacological Adverse Reaction or "Innate Hypersensitivity"? Spoerl D; Nigolian H; Czarnetzki C; Harr T Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28590439 [TBL] [Abstract][Full Text] [Related]
5. Typical antimicrobials induce mast cell degranulation and anaphylactoid reactions via MRGPRX2 and its murine homologue MRGPRB2. Zhang T; Che D; Liu R; Han S; Wang N; Zhan Y; Pundir P; Cao J; Lv Y; Yang L; Wang J; Ding M; Dong X; He L Eur J Immunol; 2017 Nov; 47(11):1949-1958. PubMed ID: 28688196 [TBL] [Abstract][Full Text] [Related]
6. Cisatracurium induces mast cell activation and pseudo-allergic reactions via MRGPRX2. Che D; Rui L; Cao J; Wang J; Zhang Y; Ding Y; Zhao T; Ma P; An H; Gao Z; Zhang T Int Immunopharmacol; 2018 Sep; 62():244-250. PubMed ID: 30032049 [TBL] [Abstract][Full Text] [Related]
7. Antibody or Anybody? Considering the Role of MRGPRX2 in Acute Drug-Induced Anaphylaxis and as a Therapeutic Target. Mackay GA; Fernandopulle NA; Ding J; McComish J; Soeding PF Front Immunol; 2021; 12():688930. PubMed ID: 34867939 [TBL] [Abstract][Full Text] [Related]
9. Mast cell-mediated hypersensitivity to fluoroquinolone is MRGPRX2 dependent. Liu R; Hu S; Zhang Y; Che D; Cao J; Wang J; Zhao T; Jia Q; Wang N; Zhang T Int Immunopharmacol; 2019 May; 70():417-427. PubMed ID: 30856392 [TBL] [Abstract][Full Text] [Related]
10. Roles of Mas-related G protein-coupled receptor X2 on mast cell-mediated host defense, pseudoallergic drug reactions, and chronic inflammatory diseases. Subramanian H; Gupta K; Ali H J Allergy Clin Immunol; 2016 Sep; 138(3):700-710. PubMed ID: 27448446 [TBL] [Abstract][Full Text] [Related]
11. MRGPRX2 activation as a rapid, high-throughput mechanistic-based approach for detecting peptide-mediated human mast cell degranulation liabilities. Lafleur MA; Werner J; Fort M; Lobenhofer EK; Balazs M; Goyos A J Immunotoxicol; 2020 Dec; 17(1):110-121. PubMed ID: 32525431 [TBL] [Abstract][Full Text] [Related]
12. MRGPRX2 and Adverse Drug Reactions. McNeil BD Front Immunol; 2021; 12():676354. PubMed ID: 34421893 [TBL] [Abstract][Full Text] [Related]
13. Inhibitory function of Shikonin on MRGPRX2-mediated pseudo-allergic reactions induced by the secretagogue. Wang J; Zhang Y; Li C; Ding Y; Hu S; An H Phytomedicine; 2020 Mar; 68():153149. PubMed ID: 32032836 [TBL] [Abstract][Full Text] [Related]
14. MRGPRX2-mediated mast cell response to drugs used in perioperative procedures and anaesthesia. Navinés-Ferrer A; Serrano-Candelas E; Lafuente A; Muñoz-Cano R; Martín M; Gastaminza G Sci Rep; 2018 Aug; 8(1):11628. PubMed ID: 30072729 [TBL] [Abstract][Full Text] [Related]
15. Mast cells signal their importance in health and disease. Olivera A; Beaven MA; Metcalfe DD J Allergy Clin Immunol; 2018 Aug; 142(2):381-393. PubMed ID: 29454835 [TBL] [Abstract][Full Text] [Related]
16. Mast Cell Disorders In Drug Hypersensitivity. Bonadonna P; Bonifacio M; Zanotti R Curr Pharm Des; 2016; 22(45):6862-6869. PubMed ID: 27779084 [TBL] [Abstract][Full Text] [Related]